Assisted Reproductive Technology Market Size Report, 2035

Assisted Reproductive Technology (ART) Market Size - By Product, By Procedures and By End Use - Global Forecast, 2026 to 2035

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; Procedures trends

2.2.4&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising prevalence of infertility across population base

3.2.1.2&nbsp;&nbsp;&nbsp; Demographical shift towards acceptance of assisted reproductive technology (ART)

3.2.1.3&nbsp;&nbsp;&nbsp; Technological advancements in assisted reproductive technology

3.2.1.4&nbsp;&nbsp;&nbsp; Rising awareness regarding assisted reproductive technology

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.2.2.2&nbsp;&nbsp;&nbsp; High cost of ART procedures

3.2.3&nbsp;&nbsp;&nbsp; Market opportunity

3.2.3.1&nbsp;&nbsp;&nbsp; Personalized and precision reproductive medicine

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5&nbsp;&nbsp;&nbsp; Technological landscape

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.2.1&nbsp;&nbsp;&nbsp; Global

4.2.2&nbsp;&nbsp;&nbsp; North America

4.2.3&nbsp;&nbsp;&nbsp; Europe

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Merger and acquisition

4.6.2&nbsp;&nbsp;&nbsp; Partnership and collaboration

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Media

5.2.1&nbsp;&nbsp;&nbsp; Embryo culture media

5.2.2&nbsp;&nbsp;&nbsp; Cryopreservation media

5.2.3&nbsp;&nbsp;&nbsp; Semen processing media

5.2.4&nbsp;&nbsp;&nbsp; Ovum processing media

5.3&nbsp;&nbsp;&nbsp; Instrument

5.3.1&nbsp;&nbsp;&nbsp; Vitrification devices

5.3.2&nbsp;&nbsp;&nbsp; Incubators

5.3.3&nbsp;&nbsp;&nbsp; Sperm analyzer system

5.3.4&nbsp;&nbsp;&nbsp; Micromanipulators

5.3.5&nbsp;&nbsp;&nbsp; Other instruments

5.4&nbsp;&nbsp;&nbsp; Consumables

5.4.1&nbsp;&nbsp;&nbsp; Catheters

5.4.2&nbsp;&nbsp;&nbsp; Needles

5.4.3&nbsp;&nbsp;&nbsp; Storage containers

5.4.4&nbsp;&nbsp;&nbsp; Other consumables

5.5&nbsp;&nbsp;&nbsp; Supplements

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Procedure, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Technology

6.2.1&nbsp;&nbsp;&nbsp; In-vitro fertilization (IVF)

6.2.1.1&nbsp;&nbsp;&nbsp; IVF with intracytoplasmic sperm injection (ICSI)

6.2.1.2&nbsp;&nbsp;&nbsp; IVF without ICSI

6.2.2&nbsp;&nbsp;&nbsp; Artificial insemination - intrauterine insemination (AI-IUI)

6.3&nbsp;&nbsp;&nbsp; Type

6.3.1&nbsp;&nbsp;&nbsp; Fresh donor

6.3.2&nbsp;&nbsp;&nbsp; Fresh non donor

6.3.3&nbsp;&nbsp;&nbsp; Frozen donor

6.3.4&nbsp;&nbsp;&nbsp; Frozen non donor

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Fertility clinics

7.4&nbsp;&nbsp;&nbsp; Cryobanks

7.5&nbsp;&nbsp;&nbsp; Other end use

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Esco Micro

9.2&nbsp;&nbsp;&nbsp; Gynotec

9.3&nbsp;&nbsp;&nbsp; Hamilton Thorne

9.4&nbsp;&nbsp;&nbsp; Indira IVF Hospital

9.5&nbsp;&nbsp;&nbsp; Ivy Fertility

9.6&nbsp;&nbsp;&nbsp; Kitazato

9.7&nbsp;&nbsp;&nbsp; Laboratoire

9.8&nbsp;&nbsp;&nbsp; Liverpool Partners Group

9.9&nbsp;&nbsp;&nbsp; Merck

9.10&nbsp;&nbsp;&nbsp; MISTRAL FERTILITY CLINICS

9.11&nbsp;&nbsp;&nbsp; NidaCon International

9.12&nbsp;&nbsp;&nbsp; The Cooper Companies

9.13&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

9.14&nbsp;&nbsp;&nbsp; Vitrolife Group

9.15&nbsp;&nbsp;&nbsp; Western Fertility Institute

&nbsp;&nbsp;&nbsp;

Assisted Reproductive Technology ART Market

Get a free sample of this report